カスパーゼ8のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Caspase 8 Market Insights and Forecast to 2028

• レポートコード：QY2203B02252 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、73ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のカスパーゼ8の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカスパーゼ8の世界市場のxxx％を占める「IDN-7314」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「肝硬変」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のカスパーゼ8の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのカスパーゼ8市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのカスパーゼ8市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 カスパーゼ8のグローバル主要メーカーには、BeyondSpring Pharmaceuticals Inc、Conatus Pharmaceuticals Inc、Novartis AGなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 カスパーゼ8市場は、種類と用途によって区分されます。世界のカスパーゼ8市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 IDN-7314、MBRI-001、ニボカサン、プリナブリン、その他 【用途別セグメント】 肝硬変、転移性脳腫瘍、膵臓がん、門脈圧亢進症、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - カスパーゼ8製品概要 - 種類別市場（IDN-7314、MBRI-001、ニボカサン、プリナブリン、その他） - 用途別市場（肝硬変、転移性脳腫瘍、膵臓がん、門脈圧亢進症、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のカスパーゼ8販売量予測2017-2028 - 世界のカスパーゼ8売上予測2017-2028 - カスパーゼ8の地域別販売量 - カスパーゼ8の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別カスパーゼ8販売量 - 主要メーカー別カスパーゼ8売上 - 主要メーカー別カスパーゼ8価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（IDN-7314、MBRI-001、ニボカサン、プリナブリン、その他） - カスパーゼ8の種類別販売量 - カスパーゼ8の種類別売上 - カスパーゼ8の種類別価格 ・用途別市場規模（肝硬変、転移性脳腫瘍、膵臓がん、門脈圧亢進症、その他） - カスパーゼ8の用途別販売量 - カスパーゼ8の用途別売上 - カスパーゼ8の用途別価格 ・北米市場 - 北米のカスパーゼ8市場規模（種類別、用途別） - 主要国別のカスパーゼ8市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのカスパーゼ8市場規模（種類別、用途別） - 主要国別のカスパーゼ8市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のカスパーゼ8市場規模（種類別、用途別） - 主要国別のカスパーゼ8市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のカスパーゼ8市場規模（種類別、用途別） - 主要国別のカスパーゼ8市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのカスパーゼ8市場規模（種類別、用途別） - 主要国別のカスパーゼ8市場規模（トルコ、サウジアラビア） ・企業情報 BeyondSpring Pharmaceuticals Inc、Conatus Pharmaceuticals Inc、Novartis AG ・産業チェーン及び販売チャネル分析 - カスパーゼ8の産業チェーン分析 - カスパーゼ8の原材料 - カスパーゼ8の生産プロセス - カスパーゼ8の販売及びマーケティング - カスパーゼ8の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - カスパーゼ8の産業動向 - カスパーゼ8のマーケットドライバー - カスパーゼ8の課題 - カスパーゼ8の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Caspase 8 Market
Due to the COVID-19 pandemic, the global Caspase 8 market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, IDN-7314 accounting for % of the Caspase 8 global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Liver Cirrhosis segment is altered to an % CAGR throughout this forecast period.
China Caspase 8 market size is valued at US$ million in 2021, while the US and Europe Caspase 8 are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Caspase 8 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Caspase 8 include BeyondSpring Pharmaceuticals Inc, Conatus Pharmaceuticals Inc and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Caspase 8 Scope and Segment
Caspase 8 market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Caspase 8 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
IDN-7314
MBRI-001
Nivocasan
Plinabulin
Others
Segment by Application
Liver Cirrhosis
Metastatic Brain Tumor
Pancreatic Cancer
Portal Hypertension
Others
By Company
BeyondSpring Pharmaceuticals Inc
Conatus Pharmaceuticals Inc
Novartis AG
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Caspase 8 Product Introduction
1.2 Market by Type
1.2.1 Global Caspase 8 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 IDN-7314
1.2.3 MBRI-001
1.2.4 Nivocasan
1.2.5 Plinabulin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Caspase 8 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Liver Cirrhosis
1.3.3 Metastatic Brain Tumor
1.3.4 Pancreatic Cancer
1.3.5 Portal Hypertension
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Caspase 8 Sales Estimates and Forecasts 2017-2028
2.2 Global Caspase 8 Revenue Estimates and Forecasts 2017-2028
2.3 Global Caspase 8 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Caspase 8 Sales by Region
2.4.1 Global Caspase 8 Sales by Region (2017-2022)
2.4.2 Global Sales Caspase 8 by Region (2023-2028)
2.5 Global Caspase 8 Revenue by Region
2.5.1 Global Caspase 8 Revenue by Region (2017-2022)
2.5.2 Global Caspase 8 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Caspase 8 Sales by Manufacturers
3.1.1 Global Top Caspase 8 Manufacturers by Sales (2017-2022)
3.1.2 Global Caspase 8 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Caspase 8 in 2021
3.2 Global Caspase 8 Revenue by Manufacturers
3.2.1 Global Caspase 8 Revenue by Manufacturers (2017-2022)
3.2.2 Global Caspase 8 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Caspase 8 Revenue in 2021
3.3 Global Caspase 8 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Caspase 8 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Caspase 8 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Caspase 8 Sales by Type
4.1.1 Global Caspase 8 Historical Sales by Type (2017-2022)
4.1.2 Global Caspase 8 Forecasted Sales by Type (2023-2028)
4.1.3 Global Caspase 8 Sales Market Share by Type (2017-2028)
4.2 Global Caspase 8 Revenue by Type
4.2.1 Global Caspase 8 Historical Revenue by Type (2017-2022)
4.2.2 Global Caspase 8 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Caspase 8 Revenue Market Share by Type (2017-2028)
4.3 Global Caspase 8 Price by Type
4.3.1 Global Caspase 8 Price by Type (2017-2022)
4.3.2 Global Caspase 8 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Caspase 8 Sales by Application
5.1.1 Global Caspase 8 Historical Sales by Application (2017-2022)
5.1.2 Global Caspase 8 Forecasted Sales by Application (2023-2028)
5.1.3 Global Caspase 8 Sales Market Share by Application (2017-2028)
5.2 Global Caspase 8 Revenue by Application
5.2.1 Global Caspase 8 Historical Revenue by Application (2017-2022)
5.2.2 Global Caspase 8 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Caspase 8 Revenue Market Share by Application (2017-2028)
5.3 Global Caspase 8 Price by Application
5.3.1 Global Caspase 8 Price by Application (2017-2022)
5.3.2 Global Caspase 8 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Caspase 8 Market Size by Type
6.1.1 North America Caspase 8 Sales by Type (2017-2028)
6.1.2 North America Caspase 8 Revenue by Type (2017-2028)
6.2 North America Caspase 8 Market Size by Application
6.2.1 North America Caspase 8 Sales by Application (2017-2028)
6.2.2 North America Caspase 8 Revenue by Application (2017-2028)
6.3 North America Caspase 8 Market Size by Country
6.3.1 North America Caspase 8 Sales by Country (2017-2028)
6.3.2 North America Caspase 8 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Caspase 8 Market Size by Type
7.1.1 Europe Caspase 8 Sales by Type (2017-2028)
7.1.2 Europe Caspase 8 Revenue by Type (2017-2028)
7.2 Europe Caspase 8 Market Size by Application
7.2.1 Europe Caspase 8 Sales by Application (2017-2028)
7.2.2 Europe Caspase 8 Revenue by Application (2017-2028)
7.3 Europe Caspase 8 Market Size by Country
7.3.1 Europe Caspase 8 Sales by Country (2017-2028)
7.3.2 Europe Caspase 8 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Caspase 8 Market Size by Type
8.1.1 Asia Pacific Caspase 8 Sales by Type (2017-2028)
8.1.2 Asia Pacific Caspase 8 Revenue by Type (2017-2028)
8.2 Asia Pacific Caspase 8 Market Size by Application
8.2.1 Asia Pacific Caspase 8 Sales by Application (2017-2028)
8.2.2 Asia Pacific Caspase 8 Revenue by Application (2017-2028)
8.3 Asia Pacific Caspase 8 Market Size by Region
8.3.1 Asia Pacific Caspase 8 Sales by Region (2017-2028)
8.3.2 Asia Pacific Caspase 8 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Caspase 8 Market Size by Type
9.1.1 Latin America Caspase 8 Sales by Type (2017-2028)
9.1.2 Latin America Caspase 8 Revenue by Type (2017-2028)
9.2 Latin America Caspase 8 Market Size by Application
9.2.1 Latin America Caspase 8 Sales by Application (2017-2028)
9.2.2 Latin America Caspase 8 Revenue by Application (2017-2028)
9.3 Latin America Caspase 8 Market Size by Country
9.3.1 Latin America Caspase 8 Sales by Country (2017-2028)
9.3.2 Latin America Caspase 8 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Caspase 8 Market Size by Type
10.1.1 Middle East and Africa Caspase 8 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Caspase 8 Revenue by Type (2017-2028)
10.2 Middle East and Africa Caspase 8 Market Size by Application
10.2.1 Middle East and Africa Caspase 8 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Caspase 8 Revenue by Application (2017-2028)
10.3 Middle East and Africa Caspase 8 Market Size by Country
10.3.1 Middle East and Africa Caspase 8 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Caspase 8 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 BeyondSpring Pharmaceuticals Inc
11.1.1 BeyondSpring Pharmaceuticals Inc Corporation Information
11.1.2 BeyondSpring Pharmaceuticals Inc Overview
11.1.3 BeyondSpring Pharmaceuticals Inc Caspase 8 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 BeyondSpring Pharmaceuticals Inc Caspase 8 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BeyondSpring Pharmaceuticals Inc Recent Developments
11.2 Conatus Pharmaceuticals Inc
11.2.1 Conatus Pharmaceuticals Inc Corporation Information
11.2.2 Conatus Pharmaceuticals Inc Overview
11.2.3 Conatus Pharmaceuticals Inc Caspase 8 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Conatus Pharmaceuticals Inc Caspase 8 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Conatus Pharmaceuticals Inc Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Corporation Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Caspase 8 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis AG Caspase 8 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Caspase 8 Industry Chain Analysis
12.2 Caspase 8 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Caspase 8 Production Mode & Process
12.4 Caspase 8 Sales and Marketing
12.4.1 Caspase 8 Sales Channels
12.4.2 Caspase 8 Distributors
12.5 Caspase 8 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Caspase 8 Industry Trends
13.2 Caspase 8 Market Drivers
13.3 Caspase 8 Market Challenges
13.4 Caspase 8 Market Restraints
14 Key Findings in The Global Caspase 8 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Caspase 8 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of IDN-7314
Table 3. Major Manufacturers of MBRI-001
Table 4. Major Manufacturers of Nivocasan
Table 5. Major Manufacturers of Plinabulin
Table 6. Major Manufacturers of Others
Table 7. Global Caspase 8 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Caspase 8 Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Caspase 8 Sales by Region (2017-2022) & (K Pcs)
Table 10. Global Caspase 8 Sales Market Share by Region (2017-2022)
Table 11. Global Caspase 8 Sales by Region (2023-2028) & (K Pcs)
Table 12. Global Caspase 8 Sales Market Share by Region (2023-2028)
Table 13. Global Caspase 8 Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Caspase 8 Revenue Market Share by Region (2017-2022)
Table 15. Global Caspase 8 Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Caspase 8 Revenue Market Share by Region (2023-2028)
Table 17. Global Caspase 8 Sales by Manufacturers (2017-2022) & (K Pcs)
Table 18. Global Caspase 8 Sales Share by Manufacturers (2017-2022)
Table 19. Global Caspase 8 Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Caspase 8 Revenue Share by Manufacturers (2017-2022)
Table 21. Caspase 8 Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 22. Global Caspase 8 Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Caspase 8 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Caspase 8 as of 2021)
Table 24. Caspase 8 Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Caspase 8 Product Offered
Table 26. Date of Manufacturers Enter into Caspase 8 Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Caspase 8 Sales by Type (2017-2022) & (K Pcs)
Table 29. Global Caspase 8 Sales by Type (2023-2028) & (K Pcs)
Table 30. Global Caspase 8 Sales Share by Type (2017-2022)
Table 31. Global Caspase 8 Sales Share by Type (2023-2028)
Table 32. Global Caspase 8 Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Caspase 8 Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Caspase 8 Revenue Share by Type (2017-2022)
Table 35. Global Caspase 8 Revenue Share by Type (2023-2028)
Table 36. Caspase 8 Price by Type (2017-2022) & (USD/Pcs)
Table 37. Global Caspase 8 Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 38. Global Caspase 8 Sales by Application (2017-2022) & (K Pcs)
Table 39. Global Caspase 8 Sales by Application (2023-2028) & (K Pcs)
Table 40. Global Caspase 8 Sales Share by Application (2017-2022)
Table 41. Global Caspase 8 Sales Share by Application (2023-2028)
Table 42. Global Caspase 8 Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Caspase 8 Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Caspase 8 Revenue Share by Application (2017-2022)
Table 45. Global Caspase 8 Revenue Share by Application (2023-2028)
Table 46. Caspase 8 Price by Application (2017-2022) & (USD/Pcs)
Table 47. Global Caspase 8 Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 48. North America Caspase 8 Sales by Type (2017-2022) & (K Pcs)
Table 49. North America Caspase 8 Sales by Type (2023-2028) & (K Pcs)
Table 50. North America Caspase 8 Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Caspase 8 Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Caspase 8 Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Caspase 8 Sales by Application (2023-2028) & (K Pcs)
Table 54. North America Caspase 8 Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Caspase 8 Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Caspase 8 Sales by Country (2017-2022) & (K Pcs)
Table 57. North America Caspase 8 Sales by Country (2023-2028) & (K Pcs)
Table 58. North America Caspase 8 Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Caspase 8 Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Caspase 8 Sales by Type (2017-2022) & (K Pcs)
Table 61. Europe Caspase 8 Sales by Type (2023-2028) & (K Pcs)
Table 62. Europe Caspase 8 Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Caspase 8 Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Caspase 8 Sales by Application (2017-2022) & (K Pcs)
Table 65. Europe Caspase 8 Sales by Application (2023-2028) & (K Pcs)
Table 66. Europe Caspase 8 Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Caspase 8 Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Caspase 8 Sales by Country (2017-2022) & (K Pcs)
Table 69. Europe Caspase 8 Sales by Country (2023-2028) & (K Pcs)
Table 70. Europe Caspase 8 Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Caspase 8 Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Caspase 8 Sales by Type (2017-2022) & (K Pcs)
Table 73. Asia Pacific Caspase 8 Sales by Type (2023-2028) & (K Pcs)
Table 74. Asia Pacific Caspase 8 Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Caspase 8 Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Caspase 8 Sales by Application (2017-2022) & (K Pcs)
Table 77. Asia Pacific Caspase 8 Sales by Application (2023-2028) & (K Pcs)
Table 78. Asia Pacific Caspase 8 Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Caspase 8 Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Caspase 8 Sales by Region (2017-2022) & (K Pcs)
Table 81. Asia Pacific Caspase 8 Sales by Region (2023-2028) & (K Pcs)
Table 82. Asia Pacific Caspase 8 Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Caspase 8 Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Caspase 8 Sales by Type (2017-2022) & (K Pcs)
Table 85. Latin America Caspase 8 Sales by Type (2023-2028) & (K Pcs)
Table 86. Latin America Caspase 8 Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Caspase 8 Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Caspase 8 Sales by Application (2017-2022) & (K Pcs)
Table 89. Latin America Caspase 8 Sales by Application (2023-2028) & (K Pcs)
Table 90. Latin America Caspase 8 Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Caspase 8 Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Caspase 8 Sales by Country (2017-2022) & (K Pcs)
Table 93. Latin America Caspase 8 Sales by Country (2023-2028) & (K Pcs)
Table 94. Latin America Caspase 8 Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Caspase 8 Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Caspase 8 Sales by Type (2017-2022) & (K Pcs)
Table 97. Middle East and Africa Caspase 8 Sales by Type (2023-2028) & (K Pcs)
Table 98. Middle East and Africa Caspase 8 Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Caspase 8 Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Caspase 8 Sales by Application (2017-2022) & (K Pcs)
Table 101. Middle East and Africa Caspase 8 Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East and Africa Caspase 8 Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Caspase 8 Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Caspase 8 Sales by Country (2017-2022) & (K Pcs)
Table 105. Middle East and Africa Caspase 8 Sales by Country (2023-2028) & (K Pcs)
Table 106. Middle East and Africa Caspase 8 Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Caspase 8 Revenue by Country (2023-2028) & (US$ Million)
Table 108. BeyondSpring Pharmaceuticals Inc Corporation Information
Table 109. BeyondSpring Pharmaceuticals Inc Description and Major Businesses
Table 110. BeyondSpring Pharmaceuticals Inc Caspase 8 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 111. BeyondSpring Pharmaceuticals Inc Caspase 8 Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. BeyondSpring Pharmaceuticals Inc Recent Developments
Table 113. Conatus Pharmaceuticals Inc Corporation Information
Table 114. Conatus Pharmaceuticals Inc Description and Major Businesses
Table 115. Conatus Pharmaceuticals Inc Caspase 8 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 116. Conatus Pharmaceuticals Inc Caspase 8 Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Conatus Pharmaceuticals Inc Recent Developments
Table 118. Novartis AG Corporation Information
Table 119. Novartis AG Description and Major Businesses
Table 120. Novartis AG Caspase 8 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 121. Novartis AG Caspase 8 Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Novartis AG Recent Developments
Table 123. Key Raw Materials Lists
Table 124. Raw Materials Key Suppliers Lists
Table 125. Caspase 8 Distributors List
Table 126. Caspase 8 Customers List
Table 127. Caspase 8 Market Trends
Table 128. Caspase 8 Market Drivers
Table 129. Caspase 8 Market Challenges
Table 130. Caspase 8 Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Caspase 8 Product Picture
Figure 3. Global Caspase 8 Market Share by Type in 2021 & 2028
Figure 3. IDN-7314 Product Picture
Figure 4. MBRI-001 Product Picture
Figure 5. Nivocasan Product Picture
Figure 6. Plinabulin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Caspase 8 Market Share by Application in 2021 & 2028
Figure 9. Liver Cirrhosis
Figure 10. Metastatic Brain Tumor
Figure 11. Pancreatic Cancer
Figure 12. Portal Hypertension
Figure 13. Others
Figure 14. Caspase 8 Report Years Considered
Figure 15. Global Caspase 8 Sales 2017-2028 (K Pcs)
Figure 16. Global Caspase 8 Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Caspase 8 Revenue 2017-2028 (US$ Million)
Figure 18. Global Caspase 8 Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Caspase 8 Sales Market Share by Region (2017-2022)
Figure 20. Global Caspase 8 Sales Market Share by Region (2023-2028)
Figure 21. North America Caspase 8 Sales YoY (2017-2028) & (K Pcs)
Figure 22. North America Caspase 8 Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Caspase 8 Sales YoY (2017-2028) & (K Pcs)
Figure 24. Europe Caspase 8 Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Caspase 8 Sales YoY (2017-2028) & (K Pcs)
Figure 26. Asia-Pacific Caspase 8 Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Caspase 8 Sales YoY (2017-2028) & (K Pcs)
Figure 28. Latin America Caspase 8 Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Caspase 8 Sales YoY (2017-2028) & (K Pcs)
Figure 30. Middle East & Africa Caspase 8 Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Caspase 8 Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Caspase 8 in the World: Market Share by Caspase 8 Revenue in 2021
Figure 33. Global Caspase 8 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Caspase 8 Sales Market Share by Type (2017-2028)
Figure 35. Global Caspase 8 Revenue Market Share by Type (2017-2028)
Figure 36. Global Caspase 8 Sales Market Share by Application (2017-2028)
Figure 37. Global Caspase 8 Revenue Market Share by Application (2017-2028)
Figure 38. North America Caspase 8 Sales Market Share by Type (2017-2028)
Figure 39. North America Caspase 8 Revenue Market Share by Type (2017-2028)
Figure 40. North America Caspase 8 Sales Market Share by Application (2017-2028)
Figure 41. North America Caspase 8 Revenue Market Share by Application (2017-2028)
Figure 42. North America Caspase 8 Sales Share by Country (2017-2028)
Figure 43. North America Caspase 8 Revenue Share by Country (2017-2028)
Figure 44. U.S. Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Caspase 8 Sales Market Share by Type (2017-2028)
Figure 47. Europe Caspase 8 Revenue Market Share by Type (2017-2028)
Figure 48. Europe Caspase 8 Sales Market Share by Application (2017-2028)
Figure 49. Europe Caspase 8 Revenue Market Share by Application (2017-2028)
Figure 50. Europe Caspase 8 Sales Share by Country (2017-2028)
Figure 51. Europe Caspase 8 Revenue Share by Country (2017-2028)
Figure 52. Germany Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 53. France Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Caspase 8 Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Caspase 8 Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Caspase 8 Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Caspase 8 Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Caspase 8 Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Caspase 8 Revenue Share by Region (2017-2028)
Figure 63. China Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 66. India Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Caspase 8 Sales Market Share by Type (2017-2028)
Figure 74. Latin America Caspase 8 Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Caspase 8 Sales Market Share by Application (2017-2028)
Figure 76. Latin America Caspase 8 Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Caspase 8 Sales Share by Country (2017-2028)
Figure 78. Latin America Caspase 8 Revenue Share by Country (2017-2028)
Figure 79. Mexico Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Caspase 8 Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Caspase 8 Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Caspase 8 Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Caspase 8 Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Caspase 8 Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Caspase 8 Revenue Share by Country (2017-2028)
Figure 88. Turkey Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 90. U.A.E Caspase 8 Revenue (2017-2028) & (US$ Million)
Figure 91. Caspase 8 Value Chain
Figure 92. Caspase 8 Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

---